Hetero Drugs Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is SILDENAFIL CITRATE, with a corresponding US DMF Number 21619.
Remarkably, this DMF maintains an Active status since its submission on May 15, 2008, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of November 25, 2013, and payment made on November 18, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II